Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the target of a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 7,633 shares, a decrease of 73.5% from the August 31st total of 28,773 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average trading volume of 42,981 shares, the short-interest ratio is currently 0.2 days.

Invesco Pharmaceuticals ETF Trading Up 0.3%

Shares of Invesco Pharmaceuticals ETF stock traded up $0.34 during trading on Friday, hitting $126.82. The stock had a trading volume of 14,688 shares, compared to its average volume of 35,854. The firm has a market cap of $568.15 million, a price-to-earnings ratio of 15.59 and a beta of 0.45. Invesco Pharmaceuticals ETF has a 12 month low of $90.43 and a 12 month high of $131.68. The business’s 50-day moving average is $125.49 and its 200 day moving average is $114.65.

Hedge Funds Weigh In On Invesco Pharmaceuticals ETF

A number of institutional investors have recently added to or reduced their stakes in PJP. Envestnet Asset Management Inc. raised its holdings in shares of Invesco Pharmaceuticals ETF by 35.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 36,897 shares of the company’s stock valued at $4,370,000 after acquiring an additional 9,741 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Invesco Pharmaceuticals ETF in the second quarter valued at approximately $55,000. MOR Wealth Management LLC purchased a new stake in Invesco Pharmaceuticals ETF in the second quarter valued at approximately $226,000. Secure Asset Management LLC bought a new stake in Invesco Pharmaceuticals ETF during the second quarter valued at approximately $428,000. Finally, Bank of America Corp DE lifted its position in Invesco Pharmaceuticals ETF by 234.0% during the first quarter. Bank of America Corp DE now owns 74,458 shares of the company’s stock valued at $7,726,000 after purchasing an additional 52,165 shares during the last quarter.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.